BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3963564)

  • 1. Cardiopulmonary effects of acepromazine and of the subsequent administration of ketamine in the dog.
    Farver TB; Haskins SC; Patz JD
    Am J Vet Res; 1986 Mar; 47(3):631-5. PubMed ID: 3963564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xylazine and xylazine-ketamine in dogs.
    Haskins SC; Patz JD; Farver TB
    Am J Vet Res; 1986 Mar; 47(3):636-41. PubMed ID: 3963565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine in dogs.
    Haskins SC; Farver TB; Patz JD
    Am J Vet Res; 1985 Sep; 46(9):1855-60. PubMed ID: 3931515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiopulmonary effects of a ketamine hydrochloride/acepromazine combination in healthy cats.
    Ingwersen W; Allen DG; Dyson DH; Pascoe PJ; O'Grady MR
    Can J Vet Res; 1988 Jan; 52(1):1-4. PubMed ID: 3127034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular changes in dogs given diazepam and diazepam-ketamine.
    Haskins SC; Farver TB; Patz JD
    Am J Vet Res; 1986 Apr; 47(4):795-8. PubMed ID: 3083735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic effects of anesthesia induced and maintained by intravenous administration of a climazolam-ketamine combination in ponies premedicated with acepromazine and xylazine.
    Bettschart-Wolfensberger R; Taylor PM; Sear JW; Bloomfield MR; Rentsch K; Dawling S
    Am J Vet Res; 1996 Oct; 57(10):1472-7. PubMed ID: 8896687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiorespiratory effects of glycopyrrolate-butorphanol-xylazine combination, with and without nasal administration of oxygen in dogs.
    Jacobson JD; McGrath CJ; Ko JC; Smith EP
    Am J Vet Res; 1994 Jun; 55(6):835-41. PubMed ID: 7944025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of buprenorphine in anesthetized dogs.
    Martinez EA; Hartsfield SM; Melendez LD; Matthews NS; Slater MR
    Am J Vet Res; 1997 Nov; 58(11):1280-4. PubMed ID: 9361893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiopulmonary and anesthetic effects of ketamine and its enantiomers in dogs.
    Muir WW; Hubbell JA
    Am J Vet Res; 1988 Apr; 49(4):530-4. PubMed ID: 3132069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ephedrine on cardiovascular function and oxygen delivery in isoflurane-anesthetized dogs.
    Wagner AE; Dunlop CI; Chapman PL
    Am J Vet Res; 1993 Nov; 54(11):1917-22. PubMed ID: 8291773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of three sedative protocols on glomerular filtration rate in clinically normal dogs.
    Newell SM; Ko JC; Ginn PE; Heaton-Jones TG; Hyatt DA; Cardwell AL; Mauragis DF; Harrison JM
    Am J Vet Res; 1997 May; 58(5):446-50. PubMed ID: 9140548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the cardiorespiratory effects of a combination of ketamine and propofol, propofol alone, or a combination of ketamine and diazepam before and after induction of anesthesia in dogs sedated with acepromazine and oxymorphone.
    Henao-Guerrero N; Riccó CH
    Am J Vet Res; 2014 Mar; 75(3):231-9. PubMed ID: 24564308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiorespiratory effects of induction and maintenance of anesthesia with ketamine-midazolam combination, with and without prior administration of butorphanol or oxymorphone.
    Jacobson JD; McGrath CJ; Smith EP
    Am J Vet Res; 1994 Apr; 55(4):543-50. PubMed ID: 8017701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiopulmonary effects of a ketamine/acepromazine combination in hypovolemic cats.
    Ingwersen W; Allen DG; Dyson DH; Black WD; Goldberg MT; Valliant AE
    Can J Vet Res; 1988 Oct; 52(4):423-7. PubMed ID: 3196971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reference cardiopulmonary values in normal dogs.
    Haskins S; Pascoe PJ; Ilkiw JE; Fudge J; Hopper K; Aldrich J
    Comp Med; 2005 Apr; 55(2):156-61. PubMed ID: 15884778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiopulmonary effects of halothane in hypovolemic dogs.
    Pascoe PJ; Haskins SC; Ilkiw JE; Patz JD
    Am J Vet Res; 1994 Jan; 55(1):121-6. PubMed ID: 8141484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiopulmonary effects of continuous intravenous infusion of guaifenesin, ketamine, and xylazine in ponies.
    Greene SA; Thurmon JC; Tranquilli WJ; Benson GJ
    Am J Vet Res; 1986 Nov; 47(11):2364-7. PubMed ID: 3789495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiopulmonary effects of fentanyl-droperidol, nitrous oxide, and atropine sulfate in dogs.
    Krahwinkel DJ; Sawyer DC; Eyster GE; Bender G
    Am J Vet Res; 1975 Aug; 36(08):1211-9. PubMed ID: 1155837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-related responses of spontaneously breathing, laterally recumbent horses to prolonged anesthesia with halothane.
    Steffey EP; Kelly AB; Woliner MJ
    Am J Vet Res; 1987 Jun; 48(6):952-7. PubMed ID: 3605811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiopulmonary and gastrointestinal motility effects of xylazine/ketamine-induced anesthesia in horses previously treated with glycopyrrolate.
    Singh S; McDonell WN; Young SS; Dyson DH
    Am J Vet Res; 1996 Dec; 57(12):1762-70. PubMed ID: 8950432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.